Contact
searchSearch
HMP Global
Robert Abraham, MD, FSIR, FRCPC, Dalhousie University
Conference Coverage
Potential of Imageable Glass Y90 Microspheres for Radioembolization Among Patients With Hepatocellular Carcinoma
04/18/2024

Featuring Robert Abraham, MD, FSIR, FRCPC

Featuring Robert Abraham, MD, FSIR, F...
At the 2024 SIR Annual Meeting, Robert Abraham, MD, FSIR, FRCPC, presented safety and efficacy results from a trial evaluating the use of multimodal imageable glass Y90 microspheres (Eye90 microspheres) for radioembolization for patients with...
At the 2024 SIR Annual Meeting, Robert Abraham, MD, FSIR, FRCPC, presented safety and efficacy results from a trial evaluating the use of multimodal imageable glass Y90 microspheres (Eye90 microspheres) for radioembolization for patients with...
At the 2024 SIR Annual Meeting,...
04/18/2024
IO Learning
Kevin P. Henseler, MD, FACR, Midwest Radiology
Conference Coverage
Unique Shear-Thinning Hydrogel Embolic Material Demonstrates Feasibility
04/16/2024

Featuring Kevin P. Henseler, MD, FACR

Featuring Kevin P. Henseler, MD, FACR...
Kevin P. Henseler, MD, FACR, discusses real-world experience with a unique shear-thinning hydrogel embolic material.
Kevin P. Henseler, MD, FACR, discusses real-world experience with a unique shear-thinning hydrogel embolic material.
Kevin P. Henseler, MD, FACR,...
04/16/2024
IO Learning
Daniel B. Brown, MD, FSIR
Videos
Y90 Radioembolization for Patients With Hepatocellular Carcinoma Who Have Undergone Prior Resection
04/12/2024

Featuring Daniel B. Brown, MD, FSIR

Featuring Daniel B. Brown, MD, FSIR ...
Daniel B. Brown, MD, FSIR, shares insights on an analysis of the RESiN study, evaluating the use of Y90 radioembolization for patients with hepatocellular carcinoma who had undergone previous resection.
Daniel B. Brown, MD, FSIR, shares insights on an analysis of the RESiN study, evaluating the use of Y90 radioembolization for patients with hepatocellular carcinoma who had undergone previous resection.
Daniel B. Brown, MD, FSIR,...
04/12/2024
IO Learning
Qian (Clark) Yu, MD, University of Chicago
Conference Coverage
Combining Transarterial Radioembolization and Systemic Therapy for Unresectable Cholangiocarcinoma
04/12/2024

Featuring Qian (Clark) Yu, MD

Featuring Qian (Clark) Yu, MD
At the SIR 2024 Annual Meeting, Clark Yu, MD, shared data on the combination of transarterial radioembolization with systemic capecitabine for patients with unresectable cholangiocarcinoma.
At the SIR 2024 Annual Meeting, Clark Yu, MD, shared data on the combination of transarterial radioembolization with systemic capecitabine for patients with unresectable cholangiocarcinoma.
At the SIR 2024 Annual Meeting,...
04/12/2024
IO Learning
AJ Gunn, MD, University of Alabama at Birmingham
Videos
Optimal Treatment of Patients With Central Renal Tumors
04/11/2024

Featuring AJ Gunn, MD

Featuring AJ Gunn, MD
At the 2024 SIR Annual Meeting, AJ Gunn, MD, University of Alabama at Birmingham, discussed treatment for patients with central renal tumors.
At the 2024 SIR Annual Meeting, AJ Gunn, MD, University of Alabama at Birmingham, discussed treatment for patients with central renal tumors.
At the 2024 SIR Annual Meeting,...
04/11/2024
IO Learning
Steven Ramen, MD, University of California, Los Angeles
Conference Coverage
MRI-Guided Transurethral Ultrasound Ablation for Patients With Localized Prostate Cancer
04/08/2024

Featuring Steven Raman, MD

Featuring Steven Raman, MD
At the 2024 SIR Annual Meeting, Steve Raman, MD, presented 5-year follow-up data from a trial evaluating the use of transurethral ultrasound ablation among patients with prostate cancer.
At the 2024 SIR Annual Meeting, Steve Raman, MD, presented 5-year follow-up data from a trial evaluating the use of transurethral ultrasound ablation among patients with prostate cancer.
At the 2024 SIR Annual Meeting,...
04/08/2024
IO Learning
Andrew Kennedy, MD, Sarah Cannon Research Institute
Conference Coverage
Radioembolization With Imageable Glass Y90 Microspheres for Hepatocellular Carcinoma
04/03/2024

Featuring Andrew Kennedy, MD

Featuring Andrew Kennedy, MD
At the 2024 SIR Annual Meeting, Andrew Kennedy, MD, discusses the utilization of imageable glass Y90 microspheres in radioembolization for patients with hepatocellular carcinoma.
At the 2024 SIR Annual Meeting, Andrew Kennedy, MD, discusses the utilization of imageable glass Y90 microspheres in radioembolization for patients with hepatocellular carcinoma.
At the 2024 SIR Annual Meeting,...
04/03/2024
IO Learning

It is SIR’s goal to promote the high-quality practice of interventional radiology through this and other educational programs. Meeting attendees will receive the latest information in basic and clinical research; experience techniques and technologies utilized by interventional radiologists around the world; see the latest equipment used in IR; and discuss social, political, and economic issues important to the IR community.

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use